Previous studies have demonstrated that methapyrilene hydrochloride (MP) is a rat-specific nongenotoxic carcinogen which induces liver tumors in a dose-dependent manner following chronic exposure in the diet. This study was conducted to determine the dose response of MP in the medium-term bioassay and to compare the response to tumor incidence. Two weeks following a single initiating dose of diethylnitrosamine (DEN), male F344 rats were administered MP at doses of 0, 62.5, 125, 250, or 1000 ppm in the diet for 6 weeks. A f partial hepatectomy was performed 3 weeks post-DEN. At termination, sections from the remaining three lobes were stained with GST-P antibody. Number and size of foci were measured using an image analysis system with a digitizing board. MP induced a dose-dependent increase in the number of GST ). A significantly greater number of foci were observed in the caudate lobe than in the anterior and posterior lobes. The size of individual foci was largely unaffected. This study demonstrates a strong correlation between foci induction and tumor incidence and suggests that this assay may have utility in predicting dose responses for the chronic bioassay. r > 19% society of Toxicology Methapyrilene hydrochloride (MP) is an antihistamine that was marketed for over 15 years until 1980 when it was found to be a potent hepatocarcinogen in the rat (Lijinsky et al., 1980) . No increase in tumor incidence was noted in man (Mirsalis, 1989) or seen in mice (Brennan and Creasia. 1982), guinea pigs, or hamsters (Lijinsky et al., 1983) . MP has been found to be negative in the standard battery of genetic toxicology tests (Mirsalis, 1989) . but has been positive in the mouse lymphoma assay under specific metabolic conditions (Turner et al., 1987) . Chronic exposure of male F344 rats to 125. 250. or 1000 ppm MP in the diet results 1 To whom reprint requests should be addressed.
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in a liver tumor incidence of 3, 15, and 100%, respectively (Lijinsky et al., 1980; Lijinsky, 1984) . Because MP shows a dose response over this range of doses, it was considered to be an ideal compound to test the relationship between tumors resulting from chronic exposure to MP and foci induced in the medium-term bioassay.
The medium-term bioassay designed by Solt and Farber (1976) and modified by Ito and colleagues (1988) is designed to detect rat hepatocarcinogens in a relatively short amount of time compared to the 2-year rodent bioassay. This assay, which tests for the ability of compounds to significantly increase (p < 0.05) the size or number of putative preneoplastic hepatic foci compared to control, also detects some mouse hepatocarcinogens, and more rarely, nonliver carcinogens. To date, over 200 compounds have been evaluated in the assay, with results that show a good correlation between ability of the compound to increase focus size and/or number and hepatocarcinogenic potential (Ito et al., 1988; Hasegawa and Ito, 1992) . Most of these compounds, however, have been evaluated at only one dose level, the maximum-tolerated dose (MTD). To that end, this study was conducted to determine whether foci induction in this assay shows a doseresponse relationship with MP and, if so, how foci-induction relates to tumor incidence in rats exposed chronically to MP.
METHODS
Six-week-old male F344 rats (Harlan Industries, Indianapolis, IN) were given a single lp injection of 200 mg/kg diethylnitrosamine (Chemsyn Science Laboratories, Lenexa. KS) at Week 0. and fed Purina Rodent Chow No. 5002 (Ralston Purina Co., St. Louis, MO) and water ad libitum. Two weeks later, groups containing 20 animals each were started on diet containing 0, 62.5. 125, 250. or 1000 ppm MP (Sigma Chemical Co., St. Louis. MO). One week later (Week 3), the rats were each given a two-thirds partial hepatectomy in which the left and median lobes were removed under isoflurane anesthesia. Five weeks later (Week 8). the animals were euthanized and tissue from each of the three remaining liver lobes (anterior, caudate, and posterior) was fixed in Zn-buffered formalin. Two separate tissue sections (6 fim) were prepared from each lobe and then stained using the StrAviGen Supersensitive Detection Kit (rabbit) by BioGenex Laboratories (San Ramon, CA) with glutathione 5-transferase, placental form (GST-P) primary polyclonal antibody to detect positive staining foci. Only GST-P* foci with a diameter of at least 4 hepatocytes were measured. percentage of the lobe occupied by foci) were determined by lobe, animal, and group using a digitizing board and a SigmaScan (Jandel Scientific. San Rafael, CA) image analysis system. Recent modifications have been made to the data collection technique such that current equipment includes a Macintosh Quadra 700 computer (Apple Computer, Inc., Cupertino, CA), NIH Image version 1.57 software (Rasband, 1992) , a Javelin Chromachip II color video camera (Javelin Electronics, Torrance, CA), a QuickCapture DT2255 video capture digitizer (Data Translation, Marlboro, MA), and a Leitz Orthoplan microscope (Leitz, Inc., Deerfield, IL).
Focus measurements were subjected to stereological analysis as described previously (Campbell et ai, 1982; Pugh etal., 1983) utilizing modifications of a Microsoft Excel spreadsheet developed by R. Maronpot et al, at the National Institute of Environmental Health Sciences. The original Excel program (LESTER) was modified for the present application so that measurements for all animals in a study could be evaluated on a single worksheet. Evaluation within the new program occurred in a three-stage process beginning with focus-specific calculations, progressing to animal by liver lobe summary data, and finally to treatment group summaries. In this specific study, lobe area and focus area data from SigmaScan were typed directly into the program. However, modifications developed since collection of these data allow the user to cut and paste large blocks of data from arrays captured in NIH Image into the Excel worksheet. Incorporation of all stereological calculations into a single database greatly facilitated data evaluation and will allow for easy validation of studies to meet the U.S. Food and Drug Administration Good Laboratory Practices guidelines.
A separate statistical analysis was completed for each of the measured responses (focus size, number of foci/cm 2 , and percentage of volume fraction). Observed responses were transformed prior to analysis using the square root transformation to create data values that were more normally distributed with equal variances within treatment groups. Transformed values from the three lobes of a liver were treated as repeated measurements on an animal, and the significance of changes in response to increasing doses of MP was evaluated statistically by repeated measures analysis of variance. The method of Tukey (Tukey et ai, 1985) was used to partition the effect of MP dose, both overall and within each lobe, into trend test comparisons of each dose level versus control. Carcinogenic potential was considered positive if a statistically significant increase (p < 0.05) was observed in a treated group of animals when compared to control animals receiving DEN alone.
RESULTS
Methapyrilene treatment without DEN initiation caused no formation of foci in any lobe studied; however, MP treatment caused a dose-related increase in background GST-P + staining of all hepatocytes. In DEN-initiated animals, when lobe values were combined for each animal within a group, a significant increase compared to control was seen in both the number of foci/cm 2 and percentage volume fraction at the two highest dose levels (250 and 1000 ppm MP) (Figs.  1 and 2 ). There was a large difference in responses among lobes, however. In general, the caudate lobe was the most sensitive of the three lobes, followed by the posterior and then the anterior. Focus size (volume) showed a slight but significant increase in the top dose only (Fig. 3) . This indicated that MP increased the percentage volume fraction predominately by increasing the number of foci. Although the lobes, when combined, did not show a significant difference from controls at the 125 ppm MP dose level, the number of foci/cm 2 and percentage of volume fraction were significantly elevated in the caudate lobe. Lobe differences have been previously observed following chronic exposure of MP in rats, with the majority of the effects seen initially in the left and median lobes (the caudate lobe was not examined) (Ohshima et al, 1984) . These differences arise possibly by preferential distribution or portal shunting of MP to the left and caudate lobes of the liver. A similar phenomenon has also been seen as an accumulation of DEN in the left liver lobe of treated animals (Richardson et al, 1986) .
DISCUSSION
Overall, results demonstrated a strong correlation between foci induction and tumor incidence following chronic expo- sure to MP (Table I) . Tumor incidence at the MP dose of 125 ppm has been reported as 3% (^). This dose did not induce a significant increase in focus size or number in the medium-term bioassay with combined liver lobe data. If the lobes were examined individually, however, the caudate lobe did show a significant increase at the 125 ppm dose level, both in the number of foci/cm 2 and percentage volume fraction. At the 62.5 ppm dose, no increase in number of foci/ cm 2 , percentage volume fraction, or mean focal volume was observed in any lobe examined. In previous studies, methapyrilene did not increase cell proliferation at 62.5 ppm (Richardson, et al., 1992) . In addition, it seems likely that no tumors would have been observed at 62.5 ppm had this dose been administered in the bioassay (Lijinski, 1984) .
Together these data support a NOEL for MP and suggest that a dose-response medium-term bioassay may have utility in determining NOELs for other compounds. The utilization of different doses in the medium-term bioassay could provide quantitative data for carcinogenic potential that is not currently available from many in vitro tests currently used to assess carcinogenicity. In theory these data could have use in setting doses for 2-year bioassay studies and aid in decision making on product development that are impacted by concerns of carcinogenicity. Previous work of Maekawa et al. (1992) strongly suggested a NOEL for the promoting effects of phenobarbital using GST-P and GGT in a DEN initiated model. However, these studies represent only two compounds and two histologic markers. Additional studies will be necessary to determine if carcinogens that operate through different mechanisms would show similar correlations.
In addition, the conduct of this study demonstrated practical issues that may arise in conducting the assay. Large differences were observed between caudate and anterior lobes. Although these differences did not affect the overall correlation between foci and tumors induced by MP, they could become a factor in estimating the carcinogenic dose of other compounds. Another slight difference was observed when comparing the dose-dependent effects of MP evaluated as focus area/lobe area versus focus volume/lobe volume. Previous published studies have demonstrated that there is little difference between focus measurements calculated as area or volume (Ito et al., 1989) , especially when the mean diameter of foci is relatively uniform (Campbell et ai, 1982) . The data obtained in this study, however, show a slight difference in these measurements. The caudate lobe was not significantly different from control (p = 0.051) at the 62.5 ppm MP dose level when measured relative to area (number of foci/cm 2 ), but was significantly different from control (p = 0.030) when measured volumetrically (number of foci/ cm 3 ). This slight difference may be due to the effect of data calculations required to convert foci/cm 2 to foci/cm 3 , which appeared to decrease the variance in the data. Although this difference may not be important in determining the carcinogenic potential of a compound in a maximum-tolerated-dose model, it may have important implications if the assay were to be used to further define no-effect doses of nongenotoxic carcinogens. Only additional studies will determine if these factors affect the ability of the medium-term bioassay to determine NOEL and quantify carcinogenic potential or if the correlations observed in this study are maintained no matter what carcinogen is assayed.
Although MP is a complete carcinogen in itself, it has until recently been considered generally nongenotoxic, acting as a promoter and inducing cancer by increasing cell replication (Mirsalis, 1989; Richardson, et al., 1992; Steinmetz et al., 1988) . More recent studies have indicated that MP may act as a cocarcinogen with DEN (Lijinsky et al., 1992) . The cocarcinogenic effect of MP has also been seen in rats dosed Data averaged for all three lobes ± SEM. * Number of rats with hepatocellular carcinoma/number of rats examined (Lijinsky, 1984; Lijinsky et al. 1980 ). ND, not determined.
* Statistically different from controls (p < 0.05).
with MP and yV-2-fluorenylacetamide (FAA), since MP increased the hepatocarcinogenicity of FAA when given before or after administration of FAA (Furuya and Williams, 1984 ). In the current study, the size of foci was largely unaffected while the number of foci increased significantly, suggesting that MP acted only as an initiator, without promoting DENinitiated foci. Since MP alone did not result in the formation of any foci (data not shown), these data support the concept that MP acts as a cocarcinogen with DEN. The mechanism by which MP functions as a cocarcinogen has not yet been determined.
